Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry.
Jonas WörmannMarc StrikStjepan JurisicKara StoutMohamed ElRefaiNina FluschnikBeat SchaerAntonius M W van StipdonkNeil T SrinivasanSylvain PlouxAlexander BreitensteinJordana KronPaul R RobertsTobias ToennisDominik K LinzRajdip DulaiJulia Hermes-LauferJayanthi N KoneruÖmer ErkünerSebastian DittrichJan-Hendrik van den BruckJan-Hendrik SchipperArian SultanKerstin Daniela RosenbergerDaniel StevenJakob LükerPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
This multicentre analysis' findings shed light on a rare but clinically highly significant adverse event in S-ICD therapy. To our knowledge, we provide the first systematic multicentre analysis investigating the incidence of sense-B-noise. Due to being difficult to diagnose and limited options for resolution, management of sense-B-noise is challenging. Complete system exchange may be the only option for some patients. Educating healthcare providers involved in S-ICD patient care is crucial for ensuring accurate diagnosis and effective management of sense-B-noise issues.
Keyphrases
- healthcare
- end stage renal disease
- air pollution
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- study protocol
- randomized controlled trial
- emergency department
- cross sectional
- heart failure
- stem cells
- high resolution
- social media
- electronic health record
- adverse drug
- cardiac resynchronization therapy
- health insurance